211 related articles for article (PubMed ID: 30854863)
1. Papillary thyroid carcinoma in cervical lymph nodes with vanished thyroid gland after ablation of Graves' disease by radioactive iodine.
Hamdy O; Raafat S; Saleh GA; Atallah K; M Saleh M; Shebl AM; Hegazy MA
Ann R Coll Surg Engl; 2019 May; 101(5):e122-e124. PubMed ID: 30854863
[TBL] [Abstract][Full Text] [Related]
2. Thyrotoxicosis due to metastatic papillary thyroid cancer in a patient with Graves' disease.
Basaria S; Salvatori R
J Endocrinol Invest; 2002; 25(7):639-42. PubMed ID: 12150341
[TBL] [Abstract][Full Text] [Related]
3. Follicular carcinoma of the thyroid following radioactive iodine treatment for Graves' disease.
Staffurth JS; Holl-Allen RT
Postgrad Med J; 1988 Nov; 64(757):878-80. PubMed ID: 3255938
[TBL] [Abstract][Full Text] [Related]
4. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
5. Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass.
Braga M; Graf H; Ogata A; Batista J; Hakim NC
J Endocrinol Invest; 2002 Mar; 25(3):250-3. PubMed ID: 11936468
[TBL] [Abstract][Full Text] [Related]
6. [Guidelines for radio-iodine (131I) therapy in Graves' disease and thyroid cancer].
Mori Y; Kusakabe K; Ikekubo K; Ishikawa N; Nakada K; Kanaya S; Misaki T; Yokoyama K; Kubo A; Higashi T; Itou K; Noguchi Y; Tsuchimochi S; Togawa T;
Kaku Igaku; 2005 Feb; 42(1):17-32. PubMed ID: 15794118
[TBL] [Abstract][Full Text] [Related]
7. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
Yunusa GH; Kotze T; Brink A
Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
[TBL] [Abstract][Full Text] [Related]
8. Histologic Findings and Cytological Alterations in Thyroid Nodules After Radioactive Iodine Treatment for Graves' Disease: A Diagnostic Dilemma.
El Hussein S; Omarzai Y
Int J Surg Pathol; 2017 Jun; 25(4):314-318. PubMed ID: 28201927
[TBL] [Abstract][Full Text] [Related]
9. Radioactive iodine 1311 (RAI) treatment. The nearest to the "magic bullet" but should always be preceded by a risk assessment, especially in the pediatric patient.
Lubin E
Pediatr Endocrinol Rev; 2011 Sep; 9(1):415-6. PubMed ID: 22783638
[TBL] [Abstract][Full Text] [Related]
10. [Ectopic thyroid tissue with a primary carcinoma].
Jensen PH; Pilt AP; Wittendorff HE
Ugeskr Laeger; 2017 Mar; 179(12):. PubMed ID: 28330547
[TBL] [Abstract][Full Text] [Related]
11. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
[TBL] [Abstract][Full Text] [Related]
12. Papillary thyroid carcinoma presenting as a primary renal tumor with multiple pulmonary and bone metastases: a case report.
Gezer E; Selek A; Tarkun İ; Cantürk Z; Çetinarslan B
J Med Case Rep; 2019 Apr; 13(1):95. PubMed ID: 31003598
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Metastatic Lymph Nodes in the Neck from Papillary Thyroid Carcinoma with Percutaneous Laser Ablation.
Mauri G; Cova L; Ierace T; Baroli A; Di Mauro E; Pacella CM; Goldberg SN; Solbiati L
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1023-30. PubMed ID: 26911732
[TBL] [Abstract][Full Text] [Related]
14. Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
Nishihara E; Ito Y; Kudo T; Ito M; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2021 Jun; 68(6):649-654. PubMed ID: 33551434
[TBL] [Abstract][Full Text] [Related]
15. Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.
Naveed A; Kanaan F; Tjernstrom NO
Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1837-9. PubMed ID: 19294401
[TBL] [Abstract][Full Text] [Related]
16. Submental nodal metastasis in papillary carcinoma of the thyroid.
Riju J; Thomas S
Indian J Cancer; 2019; 56(4):356-358. PubMed ID: 31607708
[TBL] [Abstract][Full Text] [Related]
17. A dual hyperthyroidism.
Pishdad GR; Pishdad R; Pishdad P
Lancet; 2012 Jul; 380(9838):306. PubMed ID: 22817976
[No Abstract] [Full Text] [Related]
18. Thyroid carcinoma after radioactive iodine therapy for Graves' disease.
Ozaki O; Ito K; Mimura T; Sugino K; Kitamura Y; Iwabuchi H; Kawano M
World J Surg; 1994; 18(4):518-21. PubMed ID: 7725738
[TBL] [Abstract][Full Text] [Related]
19. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
[No Abstract] [Full Text] [Related]
20. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
